General Electric Company (GCP)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 267.15 |
|---|---|
| 52-week range | 232.40 – 336.20 |
| Return, 1 month / 3 months | −5.6% / −15.1% |
| Return, 1 year / 3 years | +0.8% / +170.4% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -22.5% |
| Average daily value traded | 0.24M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
General Electric Company is an American industrial group whose businesses serve aviation and energy customers around the world. Its aerospace arm builds and services jet engines for commercial and military aircraft, while its energy business supplies gas turbines, grid equipment and related services to power producers. The company also has a long history in medical imaging, now run as a separate business. General Electric is based in the United States and sells to airlines, manufacturers, utilities and governments.
General Electric Company trades under the code GCP on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
General Electric Company (GCP) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 267.15 on 27 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 329 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.8% and over the last three months it fell 15.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.3% | ||
| From 52-week high | -19.3% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.1% | ||
| 6-month return | 11.6% | ||
| 12-month return, skipping the last month | 6.8% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.5% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.24M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | −5.6% |
| 3 months | −15.1% |
| 6 months | +11.6% |
| 1 year | +0.8% |
| 3 years | +170.4% |
| 5 years | +290.4% |
Signals
| 50-day / 200-day average | 279.93 / 279.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2026 | USD 0.4181 |
| 6 Jul 2026 | USD 0.4181 |
| 9 Mar 2026 | USD 0.4181 |
| 29 Dec 2025 | USD 0.3202 |
| 29 Sep 2025 | USD 0.3202 |
| 7 Jul 2025 | USD 0.3202 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.